Articles tagged with Chronic Obstructive Pulmonary Disease
A small group of COPD patients who started with noninvasive positive-pressure ventilation (NIPPV) had significantly higher mortality rates when transitioned to invasive mechanical ventilation (IMV). NIPPV use increased nationwide, but this trend was associated with a higher risk of death in patients requiring subsequent IMV treatment.
Researchers discovered that corticosteroids are ineffective for COPD patients due to reduced HDAC2 activity, which is caused by S-nitrosylation from cigarette smoke. Sulforaphane treatment restored HDAC2 activity and improved corticosteroid sensitivity in COPD patients.
Researchers identify broccoli-based compound as potential therapeutic for COPD, and discover the protective role of TLR6 in reducing asthma severity. Additionally, a signaling pathway linking high blood glucose to platelet hyperreactivity is defined, offering new targets for therapeutics.
Researchers identified sulforaphane as a potential therapeutic to augment anti-inflammatory effects of corticosteroids in individuals with COPD. This broccoli-based compound targets Nrf2 and restores glucocorticosteroid sensitivity in macrophages from COPD patients.
A new study found that heart-related treatments may improve wellbeing in some COPD patients, who often experience poor physical and mental quality of life. The research discovered a significant correlation between patients' quality of life scores and their heart rate variability.
Researchers found that a specific enzyme, iNOS, plays a key role in the development of emphysema. Blocking this enzyme with an inhibitor can prevent disease progression. The study also shows promising results for reversing lung damage using this approach.
A new study found that underweight COPD patients are 1.7-times more likely to die than those with a normal body weight. Additionally, heart disease and cardiac failure increase mortality rates among COPD patients.
A new study reveals that people with COPD are at a high risk of developing cardiovascular disease, highlighting the need for routine screening. The study found that 50.1% of patients with COPD had cardiovascular conditions, compared to 41% of those without COPD, emphasizing the importance of identifying comorbidities in clinical practice.
A new study found that 38% of patients with chronic conditions changed their preferences for CPR and mechanical ventilation over a year. Patients' decisions are influenced by factors such as health status, mobility, anxiety, and depression, highlighting the need for regular re-evaluation of advance care planning.
Researchers have identified 16 new genetic variants associated with lung function, shedding light on the molecular basis of lung diseases like COPD. The discovery could lead to targeted treatments and improved patient care.
The study found that 80% of participants reported inability to maintain their pre-COPD lifestyle, while 1 in 4 struggled to care for their children or family members. The research highlights the significant psychosocial and financial impact of COPD on working-age individuals, particularly in achieving life goals.
A new study by researchers from the UK found a link between living in river valley areas and an increased frequency of COPD symptom exacerbations. The unique climate in these areas, with high humidity and low dew point, retains particles and pollutants that can worsen lung symptoms.
A new study estimates that 27.6% of people will develop COPD by age 35, making it a significant public health concern. The risk is higher in men and those with lower socioeconomic status, emphasizing the need for increased awareness and funding to combat this chronic disease.
Adding azithromycin to daily treatment for COPD reduces acute exacerbations by 27% and improves quality of life. The study, funded by NHLBI, recruited 558 participants who took azithromycin for a year.
The American Thoracic Society (ATS) criticizes the White House's decision not to issue a final standard on ozone pollution, which poses significant health risks. Scientific studies have linked high ozone levels to severe respiratory issues and even premature death.
A common antibiotic has been found to help reduce severe wheezing and acute symptoms of chronic obstructive pulmonary disease (COPD) in a large multicenter clinical trial. Patients who received the antibiotic experienced a 27% reduction in acute flare-ups compared to those who received a placebo.
A new study by the National Institutes of Health (NIH) has found that adding azithromycin to daily treatment regimens for chronic obstructive pulmonary disease (COPD) can lower frequency and severity of flare-ups. The medication was shown to improve breathing ability and overall well-being in patients with COPD.
Patients with chronic lung illness exhibit improved emotional functioning and quality of life when they have a sense of humor, but laughing can temporarily reduce lung function. Researchers found that appreciating humor may be more beneficial than actually laughing out loud for patients with moderate to severe COPD.
The American College of Physicians and three other organizations issue new clinical recommendations for diagnosing and treating stable chronic obstructive pulmonary disease (COPD). The guidelines aim to help clinicians diagnose and manage COPD, prevent and treat exacerbations, and improve patient quality of life. In contrast, the risks...
The American College of Physicians, along with three other medical organizations, has released a joint clinical practice guideline for diagnosing and treating stable chronic obstructive pulmonary disease (COPD). The guidelines recommend obtaining spirometry to diagnose airflow obstruction in patients with respiratory symptoms, but not ...
Researchers used CT scans to identify structural changes in lungs of COPD patients linked to exacerbations. These findings suggest that distinct subgroups of patients may require targeted therapies, independent of spirometry measures.
Cigarette smoke exposure fundamentally alters airway tissue in people with chronic obstructive pulmonary disease (COPD), leading to self-perpetuating fibrotic changes. The study reveals that cigarette smoke induces the production of pro-fibrotic cytokines and activates the NF-κB pathway, contributing to COPD persistence.
A strong link between family history and COPD was found in a study of over 1,600 participants. Family history of COPD was identified as a significant risk factor for the disease, even when other factors such as smoking exposure were accounted for.
Researchers found that testing for Lynch Syndrome in all colorectal cancer patients is cost-effective and can help identify families at risk. Antiretroviral therapy also increased life expectancy for HIV patients in Africa to nearly normal levels, with men showing lower survival rates than women. In contrast, low health literacy was li...
A Johns Hopkins-led research study found that patients with chronic obstructive pulmonary disease (COPD) who use long-term inhaled corticosteroids have a 27% increased risk of bone fractures. This increased risk is particularly concerning for women, who are already at a higher fracture risk than men.
A new study suggests that people using mist inhalers to deliver the commonly prescribed COPD medication tiotropium may be 52% more likely to die. The findings raise concerns not only about the device but also about the drug itself, particularly its potential link to cardiovascular disease.
Patients with rheumatoid arthritis are two times more likely to develop chronic obstructive pulmonary disease (COPD) compared to healthy controls. The study controlling for risk factors like smoking and obesity found a significant association, suggesting a link between the two conditions
Men with COPD who use inhaled anticholinergic drugs are at higher risk of developing urinary retention. Researchers found that this risk is significant in men who have used IACs for a month or less and those with enlarged prostate glands.
Researchers found that COPD patients who participated in a self-confidence-building program increased their light physical activity immediately after training, with average gains of 20 minutes per day. However, these improvements were short-lived and did not persist beyond the end of the program.
A new study found COPD patients exercising at 60-70% of their maximum during Wii Fit workouts, comparable to low-intensity calisthenics. The lower extremity exercises approximated 70-80% of the pair's maximum, while upper extremity exercises were around 50-60%.
A new computer-based decision aid has been developed to educate patients with moderate/severe COPD on end-of-life planning, generating an accurate advance directive that reflects their wishes. Patients reported high levels of satisfaction and no decrease in hope after using the program.
A study found that clinicians under-addressed all seven end-of-life topics with their patients, with four items rarely discussed and three sometimes addressed. The researchers hope the findings will inform the development of practical skills to improve clinician-patient communication about end-of-life care.
A miniature ventilation system with a simple nasal mask can help patients with chronic obstructive pulmonary disease (COPD) become more active. Advanced COPD patients improved their distance walked by an average of 38 meters, comparable to full pulmonary rehabilitation programs.
A traditional Chinese herbal paste called Xiao Chuan has been shown to reduce the frequency of winter exacerbations of chronic obstructive pulmonary disease (COPD). The study, conducted in Beijing, found that patients treated with XCP experienced statistically significant reductions in steroid use and episodes of shortness of breath.
Researchers have discovered new compounds that relax airway muscles, potentially providing relief for patients with asthma and COPD. The compounds, which work through a different mechanism than current bronchodilators, show promise as a new class of therapeutics for treating these diseases.
Researchers have identified a gene variant associated with the onset of chronic obstructive pulmonary disease (COPD) in Caucasian men. The study found that variants in the vitamin D receptor gene influence the time to development of COPD, highlighting the potential role of vitamin D metabolic pathways in COPD risk.
A study found that high doses of vitamin D supplementation on top of a standard rehabilitation program improves exercise capacity and respiratory muscle strength in patients with COPD. However, the treatment did not significantly improve health-related quality of life.
The six-minute walking distance test (6MWD) is an effective tool for understanding disease severity in patients with chronic obstructive pulmonary disease (COPD). A three-year global study found that baseline 6MWD was predictive of hospital admission and had a steady rate of decline in patients with severe disease.
Researchers found that COPD patients' lung cells exhibit senescence, leading to increased inflammation. The study suggests that accelerated cellular aging contributes to persistent lung inflammation in COPD.
A systematic review found that PDE4 inhibitors, such as roflumilast and cilomilast, improve lung function and reduce the likelihood of a flareup in patients with COPD. However, these treatments do not increase general quality of life. Further research is needed to assess longer-term effects
A new study confirms that 'healthy' smokers exhibit gene expression changes similar to those of patients with moderate and severe COPD. Smoking is identified as a critical factor in causing these alterations. The findings support the need for developing new therapies to slow down COPD progression.
Two new studies published in Annals of Internal Medicine explore treatments for older adults with chronic obstructive pulmonary disease (COPD) and patients with severe allergic asthma. Long-acting inhaled beta-agonists were found to increase survival rates over anticholinergics, while omalizumab improved symptoms and quality-of-life sc...
The La Jolla Institute has identified LIGHT as a promising therapeutic target for chronic asthma, COPD, and other lung conditions. Blocking LIGHT's interactions with its receptors significantly inhibited airway remodeling in mouse models of chronic asthma.
A large retrospective analysis of 15,768 COPD patients found that ICS therapy significantly reduced all-cause mortality, particularly at 90-day intervals. This study contradicts previous expert assumptions and provides new insights into the use of ICS in pneumonia treatment.
Researchers at Johns Hopkins Bloomberg School of Public Health developed a non-steroid based strategy to improve lung's innate immune defense against bacterial infection in COPD patients. Sulforaphane, an ingredient present in broccoli, was used to enhance the Nrf2 pathway in the lungs.
The National Heart, Lung, and Blood Institute (NHLBI) has awarded $383,000 to nine state and local organizations to enhance COPD education initiatives across the country. These organizations will focus on increasing awareness among at-risk populations and enhancing leadership for prevention and treatment.
Researchers identified four novel biomarkers that can discriminate between healthy controls, asthmatics, and individuals with COPD. These anti-inflammatory proteins may help diagnose respiratory diseases earlier, allowing for more effective treatment.
A study published in CMAJ found patients with COPD are at a greater risk of developing shingles compared to the general population. The risk is highest for those taking oral steroids to treat COPD.
A large study found that moderate increases in bilirubin, a compound produced from hemoglobin breakdown, are associated with reduced lung cancer and chronic obstructive pulmonary disease incidence. Higher bilirubin levels were also linked to lower all-cause death rates.
The Canadian Medical Association Journal published new clinical practice guidelines for noninvasive ventilation, addressing its use in various settings. Key findings include recommending noninvasive positive-pressure ventilation as the first choice for patients with chronic obstructive pulmonary disease or cardiogenic pulmonary edema.
Researchers have identified a single 'master switch' enzyme, aldose reductase, as crucial in producing excess mucous that clogs airways of people with asthma and COPD. The discovery could lead to improved therapies for the 510 million people worldwide suffering from these diseases.
A new study reveals that COPD patients on LTOT are at a higher risk of death from non-respiratory causes such as cardiovascular disease. The study found an increase in mortality due to circulatory and digestive organ diseases, emphasizing the importance of optimized diagnostics and treatment.
A new study suggests that periodontal disease may increase the risk for respiratory infections like COPD and pneumonia. Regular oral care can help prevent periodontal disease, which has been linked to other chronic inflammatory diseases.
Research suggests moderate to severe COPD may involve an auto-immune component, with 34% of patients having abnormal ANA and AT levels in their blood. The study found a significant association between these auto-antibodies and impairment of lung function.
The number of aware COPD cases increased from 65% in 2008 to 69% in 2010, with smokers and nonsmokers showing significant gains. Despite progress, up to 30% of Americans are still unaware of the disease, which claims over 120,000 lives annually.
Research found significant associations between air pollution and COPD incidence, with stronger effects in men, obese patients, and those with pre-existing diabetes and asthma. Long-term exposure may be a true risk factor for developing severe COPD.
Researchers at the University of Gothenburg developed a new equation to calculate energy requirements for underweight COPD patients, leading to more accurate nutritional approaches. The study found that this method can help patients stop losing weight and even gain weight.
A study published in Science shows that neutrophils release enzymes that cause collateral damage to surrounding tissue, leading to chronic lung diseases. However, another enzyme LTA4H degrades a molecular fragment PGP, breaking the cycle and preventing damage.
Smokers exposed to wood smoke face a higher risk of COPD due to increased lung function reduction and epigenetic changes. Wood smoke exposure synergistically increases the risk when combined with cigarette smoking.
Patients with diabetes admitted for acute exacerbations of chronic obstructive pulmonary disease (COPD) experience longer hospital stays and are at an increased risk of death. High blood sugar may cause more severe infections due to impaired immune responses, leading to a trend towards longer hospital stays for patients with diabetes.